| |
Home : V : Vasopressin : Vasopressin and Ziprasidone
Effects and Recommendation :
Vasopressin and Ziprasidone may have additive effects on QT prolongation
It is not recommended to administer concurrent drugs that both prolong QTc interval.
Severity of the interaction : 6/6
|
Information on this interaction is found in the following publications :
----------
Product Information. Ziprasidone. Pfizer, 2001.
Publication : Ziprasidone by Product Information
> Product Information - -
|
|
|
|
|
